BioSpace News Archive

Genetown

Frequency Therapeutics Presents Results Demonstrating Sustained Improvement in Hearing Loss Patients Treated with FX-322

Evidence of Durable Hearing Improvements in Follow-Up with Patients from Phase 1/2 Study; Speech Intelligibility and Audibility Sustained for Up to 21 Months After Initial Dosing

September 13, 2020
·
10 min read
Policy

Gannex Filed US IND for Its NASH Drug ASC42, an FXR Agonist

Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. announces that it has filed investigational new drug application with US FDA for its non-alcoholic steatohepatitis drug candidate ASC42.

September 13, 2020
·
3 min read
Genetown

EMD Serono Advances Oncology Portfolio and Pipeline with New and Long-term Data in Multiple Cancers at ESMO 2020

New analyses from Phase III JAVELIN Bladder 100 study of BAVENCIO®* assess efficacy across subgroups, patient-reported outcomes and exploratory biomarkers in advanced urothelial cancer

September 13, 2020
·
19 min read
Corporate Wellness Market: Health Risk Assessment Takes the Lead across Global Firms

Employee welfare is gaining center-stage as across countries, governments demand it and companies witness benefits accrue on account of better employee well-being.

September 13, 2020
·
5 min read
Population Health Management Market: Integration of IT Solution with Population Health Management System Has Boosted Market Growth

According to a report by Transparency Market Research, the global population health management market is projected to witness a substantial growth during the tenure of 2017 to 2025.

September 13, 2020
·
4 min read
Deals

Gilead Sciences to Acquire Immunomedics

Gilead Adds TrodelvyTM, First-in-Class Antibody-Drug Conjugate Approved to Treat Triple-Negative Breast Cancer, With Promise in Other Forms of Breast Cancer and Additional Solid Tumors

September 13, 2020
·
16 min read
Drug Development

89bio to Announce Topline Results from Phase 1b/2a Study of BIO89-100 in NASH

89bio, Inc. announced that the company plans to share topline safety, tolerability and efficacy data from its Phase 1b/2a study of BIO89-100 in NASH in a pre-market press release and webcast to be held on Monday, September 14, 2020.

September 13, 2020
·
1 min read
Cell Culture Market: Chemically Defined Mediums Adaptation to Boost Market Growth

In a recent report by Transparency Market Research, the cell culture market is rapidly being adopted in the field of pharmaceuticals.

September 13, 2020
·
5 min read
Home Rehabilitation Products and Services Market: Surge in Population with Disabilities Boost Market Growth

Transparency Market Research has published a new report titled, ‘Home Rehabilitation Products & Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

September 13, 2020
·
6 min read
Policy

Statement from the Chief Public Health Officer of Canada on September 13, 2020

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement

September 13, 2020
·
2 min read